Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
Apply
Allo-QuadCAR01-T
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step